Oramed to Present a Scientific Poster at International Diabetes Federation Congress

NEW YORK, December 2, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today it will present a scientific poster at the 2019 International Diabetes Federation (IDF) Congress in Busan, South Korea to be held December 2-6. Oramed’s Chief Scientific Officer, […]